NYSE · Medical - Distribution
PBH (PBH) Stock
$55.06
+1.16%
NYSE: PBH
Healthcare
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Is the Options Market Predicting a Spike in Prestige Consumer Healthcare Stock?
Zacks · Jul 6, 2026
Prestige Consumer Healthcare Inc. Completes Acquisition of LaCorium Health, Prices $400 Million Senior Notes Offering, and Announces First Quarter Fiscal 2027 Earnings Results Date
GlobeNewswire · Jul 6, 2026
Prestige Consumer Healthcare Inc. (PBH): A Top Ariel Investments Stock to Buy Following Breathe Right Brand Acquisition
Insider Monkey · Jul 4, 2026
Alphabet Joined the Dow and Became a Top Holding in Berkshire Hathaway's Portfolio. But This Stock Could Be an Even Better Buy.
Motley Fool · Jul 3, 2026
Prestige Plans $400 Million Private Offering of Senior Notes
MT Newswires · Jun 30, 2026
Cash Flow (USD)
Valuation & Return Ratios
Ownership
Insiders Held1.38%
Institutions Held113.97%
Institutions Float Held115.56%
Peer Comparison
About PBH
PBH stock trades at $55.06 with a market capitalization of $2.61B. The stock is valued at a price-to-earnings (P/E) ratio of 11.92, price-to-book of 1.17, price-to-sales of 2.03. Over the past 52 weeks the stock has ranged between $42.62 and $85.29, and currently trades 35.4% below its 52-week high.
On profitability, PBH generates a return on equity (ROE) of 10.06%, return on capital employed of 16.37%, an operating margin of 28.37%, a net profit margin of 17.48%.